Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LDHA | P00338 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31113429 | 1.00 | SMN1; SMN2 (0.52) | SMN1; SMN2HPGDHSD17B10ALOX15LMNA | |
| SCHEMBL1193595 | 0.82 | HSD17B10 (0.54) | SMN1; SMN2HPGDHSD17B10LMNAGAA | |
| SCHEMBL31113422 | 0.82 | HSD17B10 (0.54) | SMN1; SMN2HPGDHSD17B10LMNAGAA | |
| SCHEMBL9721396 | 0.81 | SMN1; SMN2 (0.63) | SMN1; SMN2LMNAGAAKMT2AKDM4E | |
| SCHEMBL18620487 | 0.76 | SMN1; SMN2 (0.68) | SMN1; SMN2LMNAGAAKMT2AKDM4E | |
| SCHEMBL1845901 | 0.75 | SMN1; SMN2 (0.55) | SMN1; SMN2HPGDHSD17B10LMNAGAA | |
| SCHEMBL9304475 | 0.73 | HSD17B10 (0.58) | SMN1; SMN2HPGDHSD17B10ALOX15LMNA | |
| SCHEMBL17221047 | 0.73 | SMN1; SMN2 (0.57) | SMN1; SMN2HPGDLMNAGAAKMT2A | |
| SCHEMBL15810341 | 0.73 | SMN1; SMN2 (0.57) | SMN1; SMN2HPGDLMNAGAAKMT2A | |
| SCHEMBL18620878 | 0.72 | SMN1; SMN2 (0.81) | SMN1; SMN2HPGDHSD17B10ALOX15LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | claimed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | claimed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | claimed |
| EP-2931715-B1 | 3-HYDROXY-4-OXO-4H-PYRANE OR 3-HYDROXY-4-OXO-1,4-DIHYDRO-PYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE AGENTS | MERCK PATENT GMBH (DE) | 2016-12-21 | — | — | EP | claimed |
| US-20150306002-A1 | 3-HYDROXY-4-OXO-4H-PYRAN- OR 3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE SUBSTANCES | MERCK PATENT GMBH (DE) | 2015-10-29 | — | — | US | claimed |
| EP-2931715-A1 | 3-HYDROXY-4-OXO-4H-PYRAN- OR 3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE SUBSTANCES | Merck Patent GmbH (DE) | 2015-10-21 | — | — | EP | claimed |
| WO-2014090363-A1 | 3-HYDROXY-4-OXO-4H-PYRAN- OR 3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE SUBSTANCES | MERCK PATENT GMBH (DE) | 2014-06-19 | — | — | WO | claimed |
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | disclosed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | disclosed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | disclosed |
| EP-2931715-B1 | 3-HYDROXY-4-OXO-4H-PYRANE OR 3-HYDROXY-4-OXO-1,4-DIHYDRO-PYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE AGENTS | MERCK PATENT GMBH (DE) | 2016-12-21 | — | — | EP | disclosed |
| US-20150306002-A1 | 3-HYDROXY-4-OXO-4H-PYRAN- OR 3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE SUBSTANCES | MERCK PATENT GMBH (DE) | 2015-10-29 | — | — | US | disclosed |
| EP-2931715-A1 | 3-HYDROXY-4-OXO-4H-PYRAN- OR 3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE SUBSTANCES | Merck Patent GmbH (DE) | 2015-10-21 | — | — | EP | disclosed |
| WO-2014090363-A1 | 3-HYDROXY-4-OXO-4H-PYRAN- OR 3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE SUBSTANCES | MERCK PATENT GMBH (DE) | 2014-06-19 | — | — | WO | disclosed |
| EP-0544681-A1 | A NOVEL SALICYLIC ACID-MALTOL CONJUGATES. | HAN BYUNG HOON (KR) | 1993-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150306002-A1 | 3-HYDROXY-4-OXO-4H-PYRAN- OR 3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE SUBSTANCES | S100A4, CUTA, OCIAD1 | SMN1; SMN2 4821/4885HPGD 361/4885HSD17B10 3186/4885 |
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | NOD2, PYCARD, CLPP | SMN1; SMN2 4274/4885HPGD 2085/4885HSD17B10 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.